J1G-MC-LAKB - ClinicalTrials.gov - NCT04451408
J1G-MC-LAKB - ClinicalTrials.gov - NCT04451408
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have gradual and progressive changes in memory for at least 6 months
Participants must have a family member or close friend who is with the participant at least 10 hours per week and can participate in study appointments
Participants must NOT
Participants must not have other serious or unstable illnesses
Participants must not have magnetic implants or have a fear of being in an enclosed space
Participants must not have multiple or severe drug allergies
Participants must not have a serious risk for suicide
Participants must not drink alcohol heavily or abuse street drugs
Trial Summary
Conditions the trial is for
Mild Cognitive Impairment, Mild Alzheimer's, Moderate Alzheimer's, Early Symptoms of Alzheimer's Disease
What the trial is testing?
LY3372993
Could I receive a Placebo?
yes
Enrollment Goal
30
Trial Dates
July 2020 - February 2022
Trial Phase
1
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have gradual and progressive changes in memory for at least 6 months
Participants must have a family member or close friend who is with the participant at least 10 hours per week and can participate in study appointments
Participants must NOT
Participants must not have other serious or unstable illnesses
Participants must not have magnetic implants or have a fear of being in an enclosed space
Participants must not have multiple or severe drug allergies
Participants must not have a serious risk for suicide
Participants must not drink alcohol heavily or abuse street drugs
Trial Summary
Conditions the trial is for
Mild Cognitive Impairment, Mild Alzheimer's, Moderate Alzheimer's, Early Symptoms of Alzheimer's Disease
What the trial is testing?
LY3372993
Could I receive a Placebo?
yes
Enrollment Goal
30
Trial Dates
July 2020 - February 2022
Trial Phase
1
Trial Locations
Hide locations not currently recruiting